


| VistaGen Therapeutics and EverInsight Therapeutics Enter Strategic Collaboration to Develop and Commercialize PH94B for Anxiety Disorders in Greater China, South Korea and Southeast Asia |
|
Collaboration intended to support Phase 3 development and commercialization of PH94B in key Asian markets. Agreement includes $5 million upfront payment and development and commercial milestones up to $172 million. SOUTH SAN FRANCISCO, Calif. and SHANGHAI June 25, 2020 /PRNewswire/ -- VistaGen....
Posted: 2020-06-25 14:25:00
|
If you are a broadcaster or Christian program producer you can schedule a 15 min FREE consultation with an EGR specialist to help you evaluate all possible Int'l broadcasting options.
We will call you back at a number and time of your convenience, and will gladly answer any question that you may have on how to broadcast your Christian message worldwide.